Literature DB >> 12207072

Clinicopathologic features of mucinous gastric carcinoma.

Sang Woo Lim1, L S Woo, D Y Kim, Y J Kim, S K Kim.   

Abstract

BACKGROUND/AIMS: Mucinous gastric carcinoma (MGC) is a histopathologic subtype of gastric carcinoma with a poor prognosis. The purpose of this study was to compare the disease course of MGC with non-mucinous gastric carcinoma (NMGC) and study the clinicopathologic features that influence the prognosis of MGC patients.
METHODS: We reviewed the records of 2,383 patients with a confirmed histologic diagnosis of gastric carcinoma. There were 157 patients with MGC compared to 2,226 with NMGC.
RESULTS: A depth of invasion greater than T3 was more frequently found in MGC than in NMGC. The mean number of lymph nodes with metastases was 2.78 in MGC and 2.28 in NMGC (p < 0.001). There were more MGC patients with TNM stages II through IV (UICC classification). The overall survival rate was lower for the MGC group (46.5%) than for the NMGC group (64.0%; p < 0.05). Depth of invasion, lymph node metastases, and stage at diagnosis were significant factors affecting the outcome.
CONCLUSION: The factors influencing the poorer prognosis (lower 5-year survival rate) of MGC are the advanced stage at the time of diagnosis, lymph node metastases, and a higher TNM status. Mucinous histologic type itself was not an independent predictive factor in survival. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12207072     DOI: 10.1159/000064583

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  14 in total

1.  Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma.

Authors:  Zhaode Bu; Zhixue Zheng; Ziyu Li; Xiaojiang Wu; Lianhai Zhang; Aiwen Wu; Xianglong Zong; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

2.  Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma.

Authors:  Chunming Yin; Deming Li; Zhe Sun; Ting Zhang; Yan Xu; Zhenning Wang; Huimian Xu
Journal:  Med Oncol       Date:  2011-02-05       Impact factor: 3.064

3.  Characteristics and prognosis of mucinous gastric carcinoma.

Authors:  Taro Isobe; Kousuke Hashimoto; Junya Kizaki; Satoru Matono; Naotaka Murakami; Tetsushi Kinugasa; Keishiro Aoyagi; Yoshito Akagi
Journal:  Mol Clin Oncol       Date:  2014-10-22

4.  Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma.

Authors:  Jae Eun Lee; Yoon Young Choi; Ji Yeong An; Ki Tae Kim; Su-Jin Shin; Jae-Ho Cheong
Journal:  Gastric Cancer       Date:  2022-05-09       Impact factor: 7.701

5.  Effect of extramucin pools in gastric cancer patients.

Authors:  Ki-Hyun Kim; Si-Hak Lee; Cheol-Woong Choi; Su-Jin Kim; Chang-In Choi; Dae-Hwan Kim; Tae-Yong Jeon; Dong-Heon Kim; Sun-Hwi Hwang
Journal:  Ann Surg Treat Res       Date:  2015-10-28       Impact factor: 1.859

6.  The Clinicopathological Features and Long-Term Survival Outcomes of Mucinous Gastric Carcinoma: a Consecutive Series of 244 Cases from a Single Institute.

Authors:  Xiaolong Tang; Jianwei Zhang; Xu Che; Zhongmin Lan; Yingtai Chen; Chengfeng Wang
Journal:  J Gastrointest Surg       Date:  2016-01-05       Impact factor: 3.452

7.  Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component.

Authors:  Ziyu Zhu; Jialiang Gao; Zhixin Liu; Chunfeng Li; Yingwei Xue
Journal:  Biomed Res Int       Date:  2021-05-03       Impact factor: 3.411

8.  Prognosis of early mucinous gastric carcinoma.

Authors:  Seong Yeob Ryu; Ho Gun Kim; Jae Hyuk Lee; Dong Yi Kim
Journal:  Ann Surg Treat Res       Date:  2014-06-24       Impact factor: 1.859

9.  Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological types.

Authors:  Han Hong Lee; Kyo Young Song; Cho Hyun Park; Hae Myung Jeon
Journal:  World J Surg Oncol       Date:  2012-11-26       Impact factor: 2.754

10.  Mucin secretion activity of gastric cancer as a prognostic factor: a clinicopathological analysis.

Authors:  Joanna Huszno; Izolda Mrochen-Domin; Ewa Zembala-Nożyńska; Andrzej Tukiendorf; Dariusz Lange; Elżbieta Nowara
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.